FIELD: pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a composition exhibiting cytotoxic action on human bladder cancer cells. Composition, having cytotoxic action on human bladder cancer cells, contains an oil extract of juniper common, common St. John's wort herbs, common tansy flowers, rosehips fruits, rhizomes of common tormentil, rhizomes with roots of rhodiola rosea, ginseng roots, licorice roots, peppermint leaves, rhizomes with roots of valerian, oregano herb, eucalyptus viminalis leaves, common pine buds, silver birch and downy birch buds, and phenolic-free carbonous kreoline, taken in certain concentration.
EFFECT: composition described above possesses pronounced cytotoxic activity towards bladder cancer cells and can cause their death by apoptosis mechanism.
1 cl, 5 tbl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION EXHIBITING CYTOTOXICITY TOWARDS HUMAN COLON CARCINOMA CELLS | 2020 |
|
RU2747147C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| HYDROXAMIC ACIDS, 4-AMINOQUINAZOLINE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802463C1 |
| AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
| MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
| APPLICATION OF TRIINDOLYL METHANE DERIVATIVES AS ANTICANCER DRUGS | 2010 |
|
RU2454232C2 |
| HERBAL TEA COMPOSITION CONTAINING ANTLERS | 2020 |
|
RU2746625C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
